GLP-1 receptor agonist: Difference between revisions
Created page with "{{Drug List/ja|state6=uncollapsed}} {{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}} '''Glucagon-like peptide-1 (GLP-1) receptor agonists''', also known as '''GLP-1 analogs''', '''GLP-1DAs''' or '''incretin mimetics''', are a class of drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. They mimic the actions of the endogenous incretin hormone GLP-1..." |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Drug List/ja|state6=uncollapsed}} | {{Drug List/ja|state6=uncollapsed}} | ||
{{Pathnav|Medication|Diabetes medication|frame=1}} | |||
{{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}} | {{Short description|Agonist of the GLP-1 receptor used in the treatment of type 2 diabetes}} | ||